{
    "pmcid": "11474105",
    "qa_pairs": {
        "How does ABodyBuilder3 estimate uncertainty in its predictions?": [
            "By using predicted Local Distance Difference Test (pLDDT) scores",
            "Through ensemble modeling",
            "By calculating standard deviation of predictions",
            "Using Monte Carlo simulations"
        ],
        "What advantage does ABodyBuilder3's use of ProtT5 embeddings provide over one-hot encoding?": [
            "A more nuanced understanding of the antibody sequence",
            "Faster computational processing",
            "Reduced memory usage",
            "Simplified model architecture"
        ],
        "What is a direct application of ABodyBuilder3's advancements in SARS-CoV-2 research?": [
            "Design and optimization of nanobodies targeting the SARS-CoV-2 spike protein",
            "Development of vaccines against SARS-CoV-2",
            "Creation of antiviral drugs for SARS-CoV-2",
            "Improvement of diagnostic tests for SARS-CoV-2"
        ],
        "What key feature of ABodyBuilder3 improves the prediction of the CDRH3 loop?": [
            "Integration of language model embeddings (ProtT5)",
            "Use of ensemble models",
            "Increased computational power",
            "Enhanced one-hot encoding techniques"
        ],
        "Which aspect of ABodyBuilder3 contributes to its scalability and efficiency?": [
            "Vectorization and mixed precision training",
            "Increased number of parameters",
            "Use of a single precision training method",
            "Reduction in dataset size"
        ]
    }
}